.START 

Interspec Inc. expects to report a net loss of about $2.4 million, or 40 cents a share, for its third quarter, which ended Aug. 31.
In the year-earlier quarter, the company had net income of about $1 million, or 15 cents a share. 

The maker of medical diagnostic systems attributed the loss to start-up costs associated with its Apogee ultrasound imaging system. 

The company said it expects to post third-quarter sales of $12.6 million, compared with $14.9 million a year earlier. 

For the nine months, Interspec expects to report a loss of $2.4 million, or about 40 cents a share, on sales of $41.5 million.
In the year-earlier period, the company had net of $2.7 million, or 44 cents a share, on sales of $43.8 million. 

